Screening, vaccination, risk reduction, and prevention guidance grounded in current public-health and clinical recommendations.
NIH-funded AI study finds children’s speech patterns predict future depression and anxiety years before symptoms — outperforming stress ratings.
Kids’ Language May Predict Depression and Anxiety Early Read More »
A new WHO landscape review links PFAS ‘forever chemicals’ to immune, thyroid, cholesterol, and cancer risks. Here’s how to lower daily exposure.
PFAS ‘Forever Chemicals’: Health Effects and Exposure Tips Read More »
Research links GLP-1 drugs like semaglutide to a rare optic-nerve condition called NAION. What patients should know about the risk.
GLP-1 Drugs and Eye Health: What Studies Say About NAION Read More »
New research links vitamin B3 (nicotinamide) to a 66% lower glaucoma risk in adults with ocular hypertension. Here’s what the science shows.
Vitamin B3 and Glaucoma: 66% Lower Risk in New Study Read More »
Deprescribing blood pressure medication is possible for some adults. Research shows who may benefit and how to taper safely with a doctor.
Stopping Blood Pressure Medication: What Studies Show Read More »
Research suggests checking blood pressure at home leads to better control and fewer heart attacks and strokes than office readings alone.
Home Blood Pressure Monitoring: Heart and Stroke Benefits Read More »
Studies suggest statins may slightly raise weight, but heart benefits typically outweigh modest gains. Here’s what the science actually shows.
Do Statins Cause Weight Gain? What Research Shows Read More »
New research suggests GLP-1 drugs like Ozempic and Wegovy may lower the risk of several obesity-linked cancers. Here is what the science actually shows.
Can GLP-1 Weight Loss Drugs Lower Cancer Risk? Read More »
New research links glucosamine supplements to a 25% higher mortality risk in dementia patients. What users and caregivers should know.
Glucosamine and Dementia: New Study Raises Concerns Read More »
Should you take a daily aspirin? Updated USPSTF guidelines and three major trials reshaped who benefits—and who faces more harm than good.
Daily Aspirin: Who Should Still Take It in 2026 Read More »
